Research at Princess Margaret Hospital
University Health Network
610 University Ave
Toronto, M5A 3W7



ASCO 2019

Chicago, USA, June 2019

Name: Aline Fusco Fares

Presentation Type: Poster

Title: Does ethnicity affect the relationship between body mass index (BMI) and overall survival (OS) in non-small cell lung cancer (NSCLC)? A pooled analysis of 17,326 International Lung Cancer Consortium (ILCCO) patients (pts).

Name: Di Maria Jiang

Presentation Type: Poster

Title: Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma (GEAC).

Name: Lawson Eng

Presentation Type: Poster

Title: Impact of health behavior change on health utility (HU) and financial toxicity in head and neck cancer (HNC) survivors.

Name: Sally CM Lau

Presentation Type: Poster

Title: Bone metastases as predictors of treatment response and rapidly progressive disease in NSCLC patients on PD-1/PD-L1 immune checkpoint inhibitors (ICI).

Name: John R. de Almeida

Presentation Type: Poster

Title: Predictors of financial toxicity among head and neck cancer patients: A prospective cohort study.

Name: Kirstin Perdrizet

Presentation Type: Poster

Title:Non-small cell lung cancer (NSCLC) next generation sequencing (NGS) using the Oncomine Comprehensive Assay (OCA) v3: Integrating expanded genomic sequencing into the Canadian publicly funded health care model.

Name: Sebastiao N. Martins-Filho

Presentation Type: Poster

Title: Clinical, pathological and genetic predictors of patient-derived xenograft (PDX) engraftment in EGFR-mutated lung adenocarcinoma (LUAD).

Name: Lawson Eng

Presentation Type: Poster

Title: Tobacco retail availability and tobacco cessation in lung and head and neck (HN) cancer survivors.

Name: Hadas Sorotsky

Presentation Type: Poster

Title: Quantifying EpCAM heterogeneity of circulating-tumor-cells (CTCs) from small cell lung cancer (SCLC) patients.

Name: Sally CM Lau

Presentation Type: Poster

Title: Myeloid immunosuppressive state as a predictor of rapidly progressive phenotype and poor survival in advanced non-small cell lung cancer (NSCLC) patients treated with PD-1/PD-L1 inhibitors.

Name: Jaspreet K Bajwa

Presentation Type: Poster

Title: Muscle wasting, visceral and subcutaneous adiposity, inflammation, nutritional deficiencies, and metastatic esophageal cancer (MEC) prognosis.

ASCO SITC meeting

February 2019

Name: RuiQui Chen

Presentation Type: Poster

Title: Comparison of care patterns for hospitalized immune-related adverse events (irAEs) between melanoma patients on combination immune checkpoint inhibitor (ICI) therapy versus ICI monotherapy.

ASCO GI meeting

January 2019

Name: Shirley Xue Jiang

Presentation Type: Poster

Title: The Esophageal Online Patient Reported Outcomes (EsO-PRO) Questionnaire: Formal implementation and assessment of a combined clinical and research data collection tool.

ESTRO 2019

T.S. Toh, A. Bang, D. Pinto, K. Hueniken, C. Brown, W.

Xu, G. Liu, B. Lok. Outcomes of IMRT/VMAT vs 2D/3D-conformal

thoracic radiation in limited stage small-cell lung

cancer. Radiotherapy and Oncology 2019; 133 (supp 1) abstr PO-0774